In conclusion, the expression of stromal FOXC1 and tumor pERK1/2 was associated with both prognosis and underlying tumor biology, reflecting the tumor microenvironment in DLBCL. This evidence concerns the gene FOXC1 and diffuse large B-cell lymphoma.